Fundraising FoxExcel Venture Management — 2016 Investments
2 investments dated 2016 · listed companies and verified rows first · show all
Aileron Therapeutics is a clinical-stage biopharmaceutical company developing peptide and protein-based therapies for rare lung and fibrosis diseases.
BiotechCambridge, US
Manuel Aivado(Executive Officer)inBrian Windsor(President and Chief Executive Officer; Director)in
BoardSeth L. Harrison(Director)Reinhard J. Ambros(Director)Joseph A. Yanchik III(Executive Officer, Director)in
Board seatCaleb Winder· per SEC Form D
Co-investorsNovartis Venture Fund
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.